Clinect has advised that Iopidine® Eye Drops will be removed from the Pharmaceutical Benefits Scheme (PBS) from 1 April 2023, as follows:
Iopidine® Eye Drops
Iopidine® Eye Drops will remain available to patients as a private product.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates